4 Einträge gefunden

1. High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors.

   1. Lorch, A
   2. Neubauer, A
   3. Hackenthal, M
   4. Dieing, A
   5. Hartmann, J T
   6. Rick, O
   7. Bokemeyer, Carsten

   2009 - Forschungsinformationssystem des UKE
2. Combination chemotherapy with gemcitabine, oxaliplatin, and paclitaxel in patients with cisplatin-refractory or multiply relapsed germ-cell tumors: a study of the German Testicular Cancer Study Group.

   1. Bokemeyer, Carsten
   2. Oechsle, Karin
   3. Honecker, Friedemann
   4. Mayer, F
   5. Hartmann, J T
   6. Waller, C F
   7. Böhlke, I

   2008 - Forschungsinformationssystem des UKE
3. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.

   1. Sammler, C
   2. Beyer, J
   3. Bokemeyer, Carsten
   4. Hartmann, J T
   5. Rick, O

   2008 - Forschungsinformationssystem des UKE
4. Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015.

   1. Köhne, C-H
   2. De Greve, J
   3. Hartmann, J T
   4. Lang, I
   5. Vergauwe, P
   6. Becker, K
   7. Braumann, D

   2008 - Forschungsinformationssystem des UKE